Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression

Published:2015-11 Issue:Supplement 2 Volume:12 Page:S164-S168
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Bhavani Sivasubramanium¹,Yuan Xiaoyi¹,You Ran¹,Shan Ming¹,Corry David¹²³⁴,Kheradmand Farrah¹²³⁴^ORCID

Affiliation:

1. Department of Medicine

2. Department of Pathology and Immunology, and

3. Biology of Inflammation Center, Baylor College of Medicine, Houston, Texas; and

4. Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, Texas

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201503-115AW

Reference43 articles.

2. Current Controversies and Future Perspectives in Chronic Obstructive Pulmonary Disease

3. Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management

4. Should We View Chronic Obstructive Pulmonary Disease Differently after ECLIPSE?. A Clinical Perspective from the Study Team

5. COPD drugs: the urgent need for innovation

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The persistent inflammation in COPD: is autoimmunity the core mechanism?;European Respiratory Review;2024-01-31

2. Challenges in the Pharmacotherapy of COPD Subtypes;Archivos de Bronconeumología;2023-05

3. Contribution of adaptive immunity to human COPD and experimental models of emphysema;Physiological Reviews;2023-04-01

4. Role of autoimmunity in the pathogenesis of chronic obstructive pulmonary disease and pulmonary emphysema;Translational Autoimmunity;2022

5. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema;Respiratory Research;2021-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3